3-Fluoromethcathinone
<templatestyles src="Module:Hatnote/styles.css"></templatestyles>
Systematic (IUPAC) name | |
---|---|
(RS)-1-(3-Fluorophenyl)-2-methylaminopropan-1-one
|
|
Clinical data | |
Legal status |
|
Routes of administration |
Oral, intranasal, intravenous |
Identifiers | |
CAS Number | 1049677-77-1 |
PubChem | CID: 53415330 |
ChemSpider | 27523958 |
Chemical data | |
Formula | C10H12FNO |
Molecular mass | 181.209 g/mol |
|
|
|
|
(verify) |
3-Fluoromethcathinone (also known as 3-FMC) is a stimulant of the phenethylamine, amphetamine and cathinone chemical classes that has been sold online as a designer drug.[1][2] It is an structural isomer of flephedrone (4-fluoromethcathinone).
3-Fluoroisomethcathinone is produced as a by-product when 3-FMC is synthesized, the activity of this compound is unknown.[3]
Contents
Effects
This chemical's psychoactive effects are yet to be studied scientifically; however, it is suspected to be much like mephedrone, though it is also suspected to lack entactogenic quality.[3]
Legal status
In the United States, 3-FMC is Schedule I controlled substance.[4]
In the United Kingdom, 3-FMC is a controlled drug under the cathinone blanket ban.
3-FMC is a Anlage II controlled drug in Germany.
See also
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 3.0 3.1 Two cases of confirmed ingestion of the novel designer compounds: 4-methylmethcathinone (Mephedrone) and 3-fluoromethcathinone Susannah Davies et al.
- ↑ Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones Into Schedule I
- Use dmy dates from May 2014
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Cathinones
- Designer drugs
- Fluoroarenes
- Norepinephrine-dopamine releasing agents